Related references
Note: Only part of the references are listed.alpha one antitrypsin deficiency: From gene to treatment
Alice M. Wood et al.
RESPIRATION (2007)
Concentration-dependent effects of native and polymerised α1-antitrypsin on primary human monocytes, in vitro -: art. no. 11
R Aldonyte et al.
BMC CELL BIOLOGY (2004)
Role of human neutrophil peptides in lung inflammation associated with α1-antitrypsin deficiency
LT Spencer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
α1-Antitrypsin deficiency•2:: Genetic aspects of α1-antitrypsin deficiency:: phenotypes and genetic modifiers of emphysema risk
DL DeMeo et al.
THORAX (2004)
α1-Antitrypsin deficiency • 1:: Epidemiology of α1-antitrypsin deficiency
M Luisetti et al.
THORAX (2004)
Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by α1-antitrypsin
S Janciauskiene et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Augmentation therapy for alpha(1)-antitrypsin deficiency
GS Juvelekian et al.
DRUGS (2004)
Current concepts - Management of chronic obstructive pulmonary disease
ER Sutherland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Cost-effectiveness analysis of augmentation therapy for severe α1-antitrypsin deficiency
TR Gildea et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Augmentation therapy with α1-antitrypsin -: Patterns of use and adverse events
JK Stoller et al.
CHEST (2003)
Acid denaturation of α1-antitrypsin:: Characterization of a novel mechanism of serpin polymerization
GL Devlin et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
α1-Antitrypsin:: Not just an antiprotease -: Extending the half-life of a natural anti-inflammatory molecule by conjugation with polyethylene glycol
M Brantly
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Biochemical efficacy and safety of a new pooled human plasma α1-antitrypsin, respitin
JK Stoller et al.
CHEST (2002)
The effect of augmentation therapy on bronchial inflammation in α1-antitrypsin deficiency
RA Stockley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Mechanisms of disease -: Alpha1-antitrypsin deficiency -: A model for conformational diseases
RW Carrell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects
A Churg et al.
LABORATORY INVESTIGATION (2001)
Longitudinal follow-up of patients with α1-protease inhibitor deficiency before and during therapy with IV α1-protease inhibitor
M Wencker et al.
CHEST (2001)
Short-term supplementation therapy does not affect elastin degradation in severe α1-antitrypsin deficiency
DJ Gottlieb et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency - A new hypothesis with supporting data
J Lieberman
CHEST (2000)
Pathogenic α1-antitrypsin polymers are formed by reactive loop-β-sheet A linkage
P Sivasothy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Structure of a serpin-protease complex shows inhibition by deformation
JA Huntington et al.
NATURE (2000)
Should health-care systems pay for replacement therapy in patients with α1-antitrypsin deficiency?: A critical review and cost-effectiveness analysis
SA Alkins et al.
CHEST (2000)